questionsmedicales.fr
Virus
Virus à ADN
Adenoviridae
Mastadenovirus
Mastadenovirus : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mastadenovirus : Questions médicales les plus fréquentes",
"headline": "Mastadenovirus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mastadenovirus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-05",
"dateModified": "2025-03-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mastadenovirus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Adenoviridae",
"url": "https://questionsmedicales.fr/mesh/D000256",
"about": {
"@type": "MedicalCondition",
"name": "Adenoviridae",
"code": {
"@type": "MedicalCode",
"code": "D000256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénovirus humains",
"alternateName": "Adenoviruses, Human",
"url": "https://questionsmedicales.fr/mesh/D000260",
"about": {
"@type": "MedicalCondition",
"name": "Adénovirus humains",
"code": {
"@type": "MedicalCode",
"code": "D000260",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030.500.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adénovirus porcins",
"alternateName": "Adenoviruses, Porcine",
"url": "https://questionsmedicales.fr/mesh/D025662",
"about": {
"@type": "MedicalCondition",
"name": "Adénovirus porcins",
"code": {
"@type": "MedicalCode",
"code": "D025662",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030.500.675"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adénovirus simiens",
"alternateName": "Adenoviruses, Simian",
"url": "https://questionsmedicales.fr/mesh/D000261",
"about": {
"@type": "MedicalCondition",
"name": "Adénovirus simiens",
"code": {
"@type": "MedicalCode",
"code": "D000261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.280.030.500.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mastadenovirus",
"alternateName": "Mastadenovirus",
"code": {
"@type": "MedicalCode",
"code": "D017921",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Meriane Demoliner",
"url": "https://questionsmedicales.fr/author/Meriane%20Demoliner",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil."
}
},
{
"@type": "Person",
"name": "Fernando Rosado Spilki",
"url": "https://questionsmedicales.fr/author/Fernando%20Rosado%20Spilki",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil."
}
},
{
"@type": "Person",
"name": "Juliana Schons Gularte",
"url": "https://questionsmedicales.fr/author/Juliana%20Schons%20Gularte",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil."
}
},
{
"@type": "Person",
"name": "Viviane Girardi",
"url": "https://questionsmedicales.fr/author/Viviane%20Girardi",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Microbiologia Molecular, Universidade Feevale, ERS 239 no. 2755, Novo Hamburgo, RS, 93352-000, Brazil. 0178103@feevale.br."
}
},
{
"@type": "Person",
"name": "Larissa Mallmann",
"url": "https://questionsmedicales.fr/author/Larissa%20Mallmann",
"affiliation": {
"@type": "Organization",
"name": "Universidade Feevale, Instituto de Ciências da Saúde, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ADN",
"item": "https://questionsmedicales.fr/mesh/D004267"
},
{
"@type": "ListItem",
"position": 4,
"name": "Adenoviridae",
"item": "https://questionsmedicales.fr/mesh/D000256"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mastadenovirus",
"item": "https://questionsmedicales.fr/mesh/D017921"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mastadenovirus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mastadenovirus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mastadenovirus",
"description": "Comment diagnostique-t-on une infection par Mastadenovirus ?\nQuels tests sont utilisés pour identifier le Mastadenovirus ?\nLes anticorps peuvent-ils détecter le Mastadenovirus ?\nQuels symptômes orientent vers une infection par Mastadenovirus ?\nPeut-on utiliser des tests rapides pour le Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mastadenovirus",
"description": "Quels sont les symptômes courants du Mastadenovirus ?\nLe Mastadenovirus cause-t-il des symptômes gastro-intestinaux ?\nLes infections par Mastadenovirus sont-elles contagieuses ?\nLes symptômes du Mastadenovirus sont-ils graves ?\nPeut-on avoir des symptômes prolongés après une infection ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mastadenovirus",
"description": "Comment prévenir les infections par Mastadenovirus ?\nLes vaccins existent-ils contre le Mastadenovirus ?\nFaut-il éviter les lieux bondés pour prévenir l'infection ?\nLe port de masque aide-t-il à prévenir le Mastadenovirus ?\nLes surfaces doivent-elles être désinfectées pour prévenir l'infection ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mastadenovirus",
"description": "Quel est le traitement principal pour une infection par Mastadenovirus ?\nDes antiviraux sont-ils efficaces contre le Mastadenovirus ?\nComment soulager les symptômes du Mastadenovirus ?\nLes antibiotiques sont-ils utiles contre le Mastadenovirus ?\nQuand consulter un médecin pour une infection par Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mastadenovirus",
"description": "Quelles sont les complications possibles d'une infection par Mastadenovirus ?\nLe Mastadenovirus peut-il causer des infections oculaires ?\nLes personnes immunodéprimées risquent-elles plus de complications ?\nLes infections par Mastadenovirus peuvent-elles être mortelles ?\nComment surveiller les complications d'une infection par Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mastadenovirus",
"description": "Quels sont les facteurs de risque d'infection par Mastadenovirus ?\nLa saison influence-t-elle les infections par Mastadenovirus ?\nLes conditions de vie surpeuplées augmentent-elles le risque ?\nLes antécédents d'infections respiratoires augmentent-ils le risque ?\nLe stress peut-il affecter le risque d'infection par Mastadenovirus ?",
"url": "https://questionsmedicales.fr/mesh/D017921?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection par Mastadenovirus ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par PCR sur des échantillons respiratoires ou fécaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier le Mastadenovirus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les cultures virales sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les anticorps peuvent-ils détecter le Mastadenovirus ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent détecter des anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes orientent vers une infection par Mastadenovirus ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, maux de gorge et diarrhée sont des symptômes fréquents."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des tests rapides pour le Mastadenovirus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests rapides existent, mais leur sensibilité peut varier."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du Mastadenovirus ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, congestion nasale et diarrhée."
}
},
{
"@type": "Question",
"name": "Le Mastadenovirus cause-t-il des symptômes gastro-intestinaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des diarrhées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les infections par Mastadenovirus sont-elles contagieuses ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles se propagent par contact direct ou gouttelettes respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes du Mastadenovirus sont-ils graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement bénins mais peuvent être graves chez les immunodéprimés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes prolongés après une infection ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes persistants peuvent survenir, notamment la fatigue."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Mastadenovirus ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hygiène des mains et l'évitement des contacts rapprochés sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre le Mastadenovirus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé pour le Mastadenovirus."
}
},
{
"@type": "Question",
"name": "Faut-il éviter les lieux bondés pour prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les foules peut réduire le risque de transmission."
}
},
{
"@type": "Question",
"name": "Le port de masque aide-t-il à prévenir le Mastadenovirus ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de masque peut réduire la transmission par gouttelettes."
}
},
{
"@type": "Question",
"name": "Les surfaces doivent-elles être désinfectées pour prévenir l'infection ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, désinfecter les surfaces fréquemment touchées aide à prévenir la propagation."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour une infection par Mastadenovirus ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique, le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils efficaces contre le Mastadenovirus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antiviraux ne sont généralement pas efficaces contre ce virus."
}
},
{
"@type": "Question",
"name": "Comment soulager les symptômes du Mastadenovirus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des antipyrétiques peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utiles contre le Mastadenovirus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour une infection par Mastadenovirus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez si les symptômes s'aggravent ou si des complications apparaissent."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection par Mastadenovirus ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure pneumonie et bronchite, surtout chez les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Le Mastadenovirus peut-il causer des infections oculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des conjonctivites virales dans certains cas."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées risquent-elles plus de complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus susceptibles de développer des complications graves."
}
},
{
"@type": "Question",
"name": "Les infections par Mastadenovirus peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais des cas graves peuvent survenir chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications d'une infection par Mastadenovirus ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance clinique et des examens complémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection par Mastadenovirus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les jeunes enfants, les personnes âgées et les immunodéprimés sont à risque élevé."
}
},
{
"@type": "Question",
"name": "La saison influence-t-elle les infections par Mastadenovirus ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections sont plus fréquentes en hiver et au printemps."
}
},
{
"@type": "Question",
"name": "Les conditions de vie surpeuplées augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la promiscuité favorise la transmission du virus."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections respiratoires augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections respiratoires peuvent prédisposer à l'infection."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter le risque d'infection par Mastadenovirus ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....